Colorectal Cancer Trials
CALGB 80702: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus
Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

E7208: A Randomized Phase II Study of Irinotecan and Cetuximab with or Without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-Type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy